Depomed, Inc. Settles Patent Litigation Against IVAX Corporation

Published: Apr 08, 2008

MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) announced today that it has reached a settlement with IVAX Corporation and its parent company, Teva Pharmaceuticals, of all claims associated with the patent infringement lawsuit filed by Depomed against IVAX in January 2006, in which Depomed alleged infringement of Depomed’s patents (U.S. Patent Nos. 6,340,475 and 6,635,280) by IVAX’s extended release metformin hydrochloride tablets

Back to news